To address whether an increase in mitophagy is a feature of primary cells from patients with hematologic malignancies, we queried The Cancer Genome Atlas (TCGA) database for expression of markers of mitophagy in hematologic malignancies with or without the SRSF2 mutation. The gene discussed is SRSF2; the disease is hematologic disorder.